Zobrazeno 1 - 10
of 36
pro vyhledávání: '"M. A. Sirotina"'
Publikováno v:
Acta Biomedica Scientifica, Vol 9, Iss 1, Pp 222-232 (2024)
Background. It is known that the protective effect of adaptation and conditioning influence is weakened in animals with metabolic syndrome. Metabolic syndrome may be the basis for the failure of cardioprotection in clinical settings.The aim of the st
Externí odkaz:
https://doaj.org/article/3ce2a7848f2f43db983cf58e902e1a3c
Autor:
V. V. Ryabov, A. E. Gombozhapova, Yu. O. Samoilova, M. A. Sirotina, D. A. Malysheva, L. N. Maslov
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 4 (2024)
Within five years after myocardial infarction (MI), a third of patients have secondary major adverse cardiovascular events (MACEs). The first randomized clinical trials to show the effectiveness of anti-inflammatory strategies in the prevention of MA
Externí odkaz:
https://doaj.org/article/58cf9e12e92c45c8b5ae09dab921f869
Thrombus aspiration in patients with ST-segment elevation myocardial infarction: a literature review
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 7 (2023)
Thrombus aspiration has not shown significant advantages over routine percutaneous coronary intervention in reducing the incidence of major adverse cardiovascular events (MACEs) in the general heterogeneous population of patients with ST-segment elev
Externí odkaz:
https://doaj.org/article/b162a705e5b04ddc9b9acdfcae9b7db4
Autor:
N. V. Naryzhnaya, A. V. Mukhomedzyanov, B. K. Kurbatov, M. A. Sirotina, M. Kilin, V. N. Azev, L. N. Maslov
Publikováno v:
Acta Biomedica Scientifica, Vol 7, Iss 6, Pp 281-289 (2022)
Background. The discovery of new pharmacological agents for myocardial protection during reperfusion injury is an urgent goal of modern physiology and pharmacology.The aim of the study. To identify the potential for protecting the myocardium from rep
Externí odkaz:
https://doaj.org/article/842ec35470424ae39ea6e5df122df22f
Publikováno v:
The Siberian Journal of Clinical and Experimental Medicine. 38:37-45
Remote postconditioning of the heart (RPost) – performed several periods of short-term ischemia-reperfusion of an remote organ after a long period of ischemia immediately before the resumption or in the early reperfusion, which leads to a reduction
Publikováno v:
Bulletin of Experimental Biology and Medicine. 174:723-727
Autor:
S. V. Logvinov, A. V. Mukhomedzyanov, B. K. Kurbatov, M. A. Sirotina, N. V. Naryzhnaya, L. N. Maslov
Publikováno v:
Bulletin of Experimental Biology and Medicine. 174:312-317
Autor:
N. V. Naryzhnaya, S. V. Logvinov, B. K. Kurbatov, A. V. Mukhomedzyanov, M. A. Sirotina, S. N. Chepelev, F. I. Vismont, L. N. Maslov
Publikováno v:
Proceedings of the National Academy of Sciences of Belarus, Medical series. 19:38-47
Remote postconditioning (RPost) has a great therapeutic potential for protecting the myocardium during ischemiareperfusion in clinical practice. At the same time, an important problem limiting the use of conditioning effects in the clinic is the pres
Publikováno v:
Regional blood circulation and microcirculation. 20:87-91
Introduction. Increased resistance of the heart to ischemia/reperfusion (I/R) is an urgent aim of physiology, pharmacology, and cardiac surgery, since I/R injury of the heart is often the cause of cardiogenic shock and subsequent death of patients in
Autor:
M. N. Sirotina, A. M. Gortsev
Publikováno v:
Russian Physics Journal. 59:1016-1023
A flow of physical events (photons, electrons, etc.) is considered. One of the mathematical models of such flows is a modulated synchronous doubly stochastic flow of events. Analytical results for conditional and unconditional probabilities of errone